Bulgaria vs Iran: The number of people with susceptibility test result for rifampicin
Bulgaria
47.71
in 2021
Iran
46.76
in 2021
Bulgaria rank
115th
Iran rank
116th
The number of people with susceptibility test result for rifampicin over time
- Bulgaria
- Iran
How they compare
Bulgaria currently reports 47.71 against 46.76 in Iran, a difference of 0.95.
Across all 5 years both countries report, Bulgaria has been ahead every year.
Bulgaria ranks 115th and Iran ranks 116th of 146 countries.
Bulgaria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.4 | 64 | 16.4 | Bulgaria |
| 2020s | 49.92 | 45.93 | 4 | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bulgaria or Iran?
- Bulgaria, at 47.71 against 46.76 in Iran as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bulgaria and Iran?
- 0.95, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Iran?
- 5 years are reported by both, from 2017 to 2021.
- How do Bulgaria and Iran rank globally for the number of people with susceptibility test result for rifampicin?
- Bulgaria ranks 115th and Iran ranks 116th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.